JCPenney Gets $2.25...
Health Care: Drugs
AVANIR Pharmaceuticals (AVNR: NASDAQ)
$3.40 0.15 | 4.62%
05/23/13 - 04:00 PM ET
Company Cash Flow
| Sep 2012 | Sep 2011 | Sep 2010 | Sep 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -59.74M | -60.63M | -26.69M | -22.00M |
| Operating Gains/Losses | 0.00 | 9.27K | 0.00 | 266.21K |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -5.22M | -2.01M | 0.00 | 0.00 |
| (Increase) Decrease in Inventories | -278.66K | -164.34K | -56.21K | 508.65K |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | -327.63K | 1.29M | 761.37K | 762.27K |
| (Decrease) Increase In Other Current Liabilities | 6.07M | 3.71M | 551.85K | -942.52K |
| (Increase) Decrease In Other Working Capital | -3.74M | -685.42K | -1.44M | -2.57M |
| Other Non-Cash Items | 4.88M | 3.78M | 2.75M | 2.88M |
| Net Cash From Continuing Operations | -57.66M | -56.52M | -23.80M | -20.29M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -57.66M | -56.52M | -23.80M | -20.29M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 66.92K | 388.12K |
| Purchases of Property, Plant & Equipment | -813.00K | -1.82M | -213.41K | -33.01K |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | 0.00 | 0.00 | -200.00K | 0.00 |
| Other Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 2.25K |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -916.66K | -3.47M | -346.49K | 357.36K |
| Issuance of Debt | 29.61M | 0.00 | 0.00 | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 19.19M | 100.19M | 31.64M | 10.25M |
| Repayment of Long-Term Debt | 0.00 | 0.00 | 0.00 | -25.74K |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 0.00 | 575.24K | -212.66K | -186.26K |
| Net Cash From Financing Activities | 48.81M | 100.77M | 31.43M | 10.03M |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | -9.76M | 40.77M | 7.29M | -9.90M |
Portfolios with AVNR
- Portfolio NameUser Type
- ContributorEarnings Short Squeeze Play...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- Contributor10 Most Shorted Stocks in B...
- Contributor5 Stocks Under-$10 Setting ...
- Contributor5 Biotech Drug-Launch Stock...
- ContributorBreakout Stocks Of The Week...
- UserMy Portfolio
- Contributor6 Heavily Shorted Stocks 04...
Latest AVNR Headlines from TheStreet
- July Options Now Available For Avanir Pharmaceuticals (AVNR) 05.20.13 | 03:05 pm
- Arena Pharmaceuticals And 6 More Stocks To Watch 01.07.13 | 07:01 pm
- 5 Stocks Facing an Earnings Short Squeeze 12.10.12 | 12:12 pm
- 5 Stocks Under $10 Set to Soar Higher 08.30.12 | 12:08 pm
- Avanir Pharmaceuticals' CEO Presents At Canaccord Genuity 32nd Annual Growth Conference (Transcript) 08.14.12 | 02:08 pm
- Avanir Pharmaceuticals' CEO Discusses F3Q12 Results - Earnings Call Transcript 08.08.12 | 09:08 pm
- Avanir Pharmaceuticals CEO Presents At Bank Of America Merrill Lynch Health Care Conference (Transcript) 05.17.12 | 05:05 pm
- Avanir Pharmaceuticals' Presents At Deutsche Bank Securities Annual Health Care Conference (Transcript) 05.09.12 | 11:05 pm
- Avanir Pharmaceuticals' CEO Discusses F2Q2012 Results - Earnings Call Transcript 05.08.12 | 03:05 pm
- Avanir's CEO Presents At Citi 2012 Global Health Care Conference - Transcript 02.29.12 | 01:02 pm
Press Releases for AVNR
- Avanir Pharmaceuticals To Participate In Two Upcoming Investor Conferences - PR Newswire 05.22.13 | 09:05 am
- Avanir Pharmaceuticals Announces Date Of Fiscal 2013 Second Quarter Financial Results And Conference Call - PR Newswire 05.01.13 | 08:05 am
- Avanir Pharmaceuticals Receives Positive CHMP Opinion For Approval Of NUEDEXTA In Europe - PR Newswire 04.26.13 | 07:04 am
- Avanir Pharmaceuticals Announces Appointment Of Corinne Nevinny To Board Of Directors - PR Newswire 03.11.13 | 04:03 pm
- AVANIR PHARMACEUTICALS ANNOUNCES RESEARCH COLLABORATION WITH DEPARTMENT OF VETERANS AFFAIRS FOR SCREENING PSEUDOBULBAR AFFECT (PBA) SYMPTOMS IN VETERANS WITH TRAUMATIC BRAIN INJURY - PR Newswire 03.06.13 | 09:03 am
- AVANIR Pharmaceuticals To Paticipate In Two Conferences In March - PR Newswire 03.01.13 | 09:03 am
- Avanir Pharmaceuticals To Present At RBC Capital Markets' 2013 Global Healthcare Conference - PR Newswire 02.14.13 | 04:02 pm
- Avanir Pharmaceuticals Announces Positive Interim Data From Pharmacokinetic Study With Next Generation Compound AVP-786 - PR Newswire 02.07.13 | 08:02 am
- Avanir Pharmaceuticals Announces Date Of Fiscal 2013 First Quarter Financial Results And Conference Call - PR Newswire 01.30.13 | 08:01 am
- Avanir Pharmaceuticals Announces Date Of Fiscal 2012 Fourth Quarter And Year End Financial Results And Conference Call - PR Newswire 12.03.12 | 08:12 am
Partner Headlines for AVNR
- Acorda: A Biotech Company To Consider - Seeking Alpha 04.13.13 | 09:04 am
- After-Hours Earnings Report for December 12, 2012 : AVNR, INTL - NASDAQ 12.12.12 | 07:12 pm
- Neuralstem Swinging For The ALS Fences - Seeking Alpha 10.29.12 | 09:10 am
- Weekly CEO Sells Highlight: Universal Insurance Holdings Inc, Avanir Pharmaceuticals Inc, Bel ... - GuruFocus 06.30.12 | 11:06 am
- Ultimate Stock Watch List for The Supreme Court's Health Care Ruling - Benzinga 06.28.12 | 09:06 am
- Stocks To Watch: Week Of March 19-23 - Seeking Alpha 03.21.12 | 08:03 am
- Avanir Pharmaceuticals: Limelight On The Horizon - Seeking Alpha 02.17.12 | 06:02 am
- Canaccord Reiterates Buy, $6 PT on Avanir Pharmaceuticals - Benzinga 11.30.11 | 09:11 am
- Avanir - Closing Short Position - Seeking Alpha 11.27.11 | 08:11 am
- 10 Small-Cap Stocks Deeply Undervalued By Target Price - Seeking Alpha 11.11.11 | 10:11 pm
